berotek has been researched along with Diabetes Mellitus, Type 1 in 1 studies
Fenoterol: A synthetic adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic.
fenoterol : A member of the class resorcinols that is 5-(1-hydroxyethyl)benzene-1,3-diol in which one of the methyl hydrogens is replaced by a 1-(4-hydroxyphenyl)propan-2-amino group. A beta2-adrenergic agonist, it is used (as the hydrobromide salt) as a bronchodilator in the management of reversible airway obstruction.
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Titova, EA | 1 |
| Dukov, LG | 1 |
| Leonova, NV | 1 |
| Titova, LA | 1 |
| Timofeev, VV | 1 |
| Granitova, LV | 1 |
1 other study available for berotek and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
[Changes in external respiration function in response to berotek and histamine in diabetic patients].
Topics: Adolescent; Adult; Aged; Bronchial Hyperreactivity; Bronchoconstriction; Bronchodilator Agents; Diab | 2008 |